Advancedurinary
The RAAS: Renin-Angiotensin-Aldosterone System
Overview
The renin-angiotensin-aldosterone system (RAAS) is the body's long-term blood pressure and volume control circuit, and it begins in the kidney. When blood pressure, blood volume, or sodium delivery falls, juxtaglomerular cells release the enzyme renin, launching a hormonal cascade that produces angiotensin II, a potent vasoconstrictor that also triggers aldosterone, ADH, and thirst. Together these raise blood pressure and restore volume through a negative feedback loop. This lesson traces each step, the sensors involved, and the system's effects.
Learning objectives
- Identify the three triggers of renin release and the juxtaglomerular apparatus.
- Trace the cascade: renin → angiotensin I → angiotensin II → aldosterone.
- Explain the physiological effects of angiotensin II.
- Describe how aldosterone adjusts sodium, potassium, and water balance.
Feedback loops
RAAS control of blood pressure and volume negative feedback
- Blood pressure, blood volume, or distal NaCl delivery falls
- Juxtaglomerular cells release renin (triggered by low pressure, sympathetic β1 signals, or macula densa sensing)
- Renin cleaves angiotensinogen to angiotensin I
- ACE in the lungs converts angiotensin I to angiotensin II
- Angiotensin II constricts arterioles and triggers aldosterone, ADH, thirst, and sympathetic activity
- Aldosterone drives Na+ and water reabsorption in the collecting duct, expanding blood volume
- Rising pressure and volume suppress renin release, closing the negative feedback loop
The sensors: juxtaglomerular apparatus
The juxtaglomerular apparatus, where the distal tubule passes between its own glomerulus's arterioles, combines two sensors. Granular juxtaglomerular (JG) cells in the afferent arteriole wall act as baroreceptors, releasing renin when perfusion pressure falls, and respond to sympathetic stimulation (beta-1 receptors) during stress or hemorrhage. The macula densa, a plaque of specialized distal tubule cells, senses low sodium chloride delivery (which signals low GFR) and signals the JG cells. Three triggers, low pressure, sympathetic activation, and low distal NaCl, all converge on renin release.
Because GFR depends on pressure, the kidney monitors the very variable its function requires, making RAAS a self-protective circuit.
The cascade: renin to angiotensin II
Renin is an enzyme, not a typical hormone: it cleaves angiotensinogen (a liver-made plasma protein) into angiotensin I, a relatively inactive decapeptide. As blood passes through the lungs, angiotensin-converting enzyme (ACE) on pulmonary capillary endothelium clips angiotensin I into angiotensin II, the system's powerful effector octapeptide. ACE also degrades bradykinin (a vasodilator), so ACE simultaneously creates a constrictor and removes a dilator. Drugs that block ACE or angiotensin II receptors lower blood pressure by interrupting exactly this cascade.
ACE is abundant on lung capillaries, so the entire cardiac output is converted efficiently: angiotensin I becomes angiotensin II in one pass through the pulmonary circulation.
Angiotensin II: effects
Angiotensin II is one of the body's strongest vasoconstrictors, raising blood pressure within seconds by tightening arterioles. It stimulates the adrenal cortex to release aldosterone, the posterior pituitary to release ADH, and the hypothalamus to trigger thirst and salt appetite. It enhances sympathetic activity and promotes sodium reabsorption in the proximal tubule. Every effect points the same way: more vascular resistance, more water and salt retained, more volume, higher pressure. Chronically elevated angiotensin II also promotes tissue remodeling, linking long-term RAAS overactivity to cardiovascular disease.
Angiotensin II simultaneously constricts vessels, retains salt and water (via aldosterone and ADH), and drives drinking: a coordinated pressure-raising program.
Aldosterone: the salt-retaining hormone
Aldosterone, a steroid hormone from the adrenal cortex's zona glomerulosa, acts on principal cells of the collecting duct (and distal tubule). It increases the number of ENaC sodium channels and Na+/K+ ATPase pumps, driving sodium (and therefore water) reabsorption while secreting potassium into the urine. The net effect expands blood volume and raises pressure at the cost of losing potassium, which is why RAAS overactivity can cause low blood potassium. Aldosterone secretion is also stimulated directly by high plasma potassium, giving it a dual role in volume and potassium balance.
Aldosterone's exchange is explicit: for sodium reabsorbed, potassium is secreted, coupling volume regulation to potassium balance.
Closing the loop: negative feedback
As blood pressure and volume rise and distal sodium delivery normalizes, the triggers for renin release fade: JG baroreceptors sense restored pressure, sympathetic drive eases, and the macula densa detects adequate NaCl. Renin secretion falls, angiotensin II and aldosterone decline, and the system settles at a new equilibrium. Atrial natriuretic peptide (ANP), released by stretched heart atria, opposes RAAS by promoting sodium and water loss. Together, RAAS (retaining) and ANP (excreting) bracket blood volume the way ADH and thirst bracket osmolarity.
Blood pressure is regulated like temperature or osmolarity: sensors, a set point, effectors, and negative feedback that shuts the response off as the variable recovers.
Key points
- Renin release is triggered by low perfusion pressure, sympathetic (β1) stimulation, and low macula densa NaCl.
- Renin → angiotensin I → (ACE in lungs) → angiotensin II → aldosterone release.
- Angiotensin II vasoconstricts, triggers aldosterone/ADH/thirst, and boosts sympathetic activity.
- Aldosterone increases collecting-duct Na+ reabsorption (ENaC) while secreting K+, expanding volume.
- Rising pressure/volume suppresses renin, closing the negative feedback loop; ANP opposes RAAS.
Common misconceptions
✓ Truth: It operates continuously in everyone as the long-term controller of blood pressure and volume; drugs targeting it are common precisely because it is so central.
✓ Truth: Renin is an enzyme that starts the cascade; angiotensin II and aldosterone are the effectors that actually raise pressure and volume.
✓ Truth: Its main targets are renal, but it also acts on the colon, sweat glands, and salivary glands to conserve sodium wherever it can.
Practice questions
Q1. Renin is released by juxtaglomerular cells in response to:
- High blood pressure
- Low perfusion pressure, sympathetic β1 stimulation, or low macula densa NaCl
- High plasma sodium
- Low body temperature
All three signals indicate threatened filtration or volume, and all converge on renin release to activate the cascade.
Q2. Angiotensin-converting enzyme (ACE) acts primarily in the:
- Kidneys
- Pulmonary capillaries
- Liver
- Adrenal cortex
ACE on lung capillary endothelium converts angiotensin I to angiotensin II as blood passes through the pulmonary circulation.
Q3. Aldosterone raises blood pressure mainly by:
- Constricting arterioles directly
- Increasing ENaC-mediated Na+ reabsorption (with water following) in the collecting duct
- Blocking ADH
- Dilating the afferent arteriole
Aldosterone inserts ENaC channels and Na+/K+ pumps in principal cells; reabsorbed sodium drags water osmotically, expanding volume.
Q4. The RAAS negative feedback loop is closed when:
- Angiotensin II stimulates more renin
- Restored pressure and NaCl delivery suppress renin release
- Aldosterone blocks ACE
- Thirst increases
Rising pressure/volume removes the triggers (JG baroreceptor, macula densa, sympathetic), so renin, angiotensin II, and aldosterone all fall.
Click a question to reveal the answer and explanation.
Frequently asked questions
Why does the cascade go through the lungs?
ACE is highly expressed on pulmonary capillary endothelium, so angiotensin I is efficiently converted to angiotensin II as the entire cardiac output passes through the lungs.
How do ACE inhibitors lower blood pressure?
They block conversion of angiotensin I to angiotensin II, reducing vasoconstriction and aldosterone-driven salt/water retention; less angiotensin II means lower pressure.
Why can RAAS overactivity lower blood potassium?
Aldosterone-driven sodium reabsorption in the collecting duct is coupled to potassium secretion, so sustained aldosterone wastes potassium into urine.
What is the macula densa actually measuring?
Distal tubular NaCl concentration, which reflects GFR: low delivery implies low filtration pressure, signaling the JG cells to release renin.